Journal
CANCER CELL
Volume 10, Issue 4, Pages 309-319Publisher
CELL PRESS
DOI: 10.1016/j.ccr.2006.08.021
Keywords
-
Categories
Funding
- NCI NIH HHS [U01-CA86772, CA106504, CA85380, N01-CO-12400] Funding Source: Medline
- NIEHS NIH HHS [T32ES07263] Funding Source: Medline
Ask authors/readers for more resources
The androgen receptor (AR) is essential for the growth of prostate cancer cells. Here, we report that tyrosine phosphorylation of AR is induced by growth factors and elevated in hormone-refractory prostate tumors. Mutation of the major tyrosine phosphorylation site in AR significantly inhibits the growth of prostate cancer cells under androgen-depleted conditions. The Src tyrosine kinase appears to be responsible for phosphorylating AR, and there is a positive correlation of AR tyrosine phosphorylation with Src tyrosine kinase activity in human prostate tumors. Our data collectively suggest that growth factors and their downstream tyrosine kinases, which are elevated during hormone-ablation therapy, can induce tyrosine phosphorylation of AR and such modification may be important for prostate tumor growth under androgen-depleted conditions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available